Stress Hormone Epinephrine Enhances Adipogenesis in Murine Embryonic Stem Cells by Up-Regulating the Neuropeptide Y System by Han, Ruijun et al.
Stress Hormone Epinephrine Enhances Adipogenesis in
Murine Embryonic Stem Cells by Up-Regulating the
Neuropeptide Y System
Ruijun Han
1,2*, Joanna B. Kitlinska
2, William R. Munday
2, G. Ian Gallicano
3, Zofia Zukowska
1,2
1Department of Integrative Biology and Physiology, Stress Physiology Center, University of Minnesota, Minneapolis, Minnesota, United States of America, 2Departments
of Physiology & Biophysics, Georgetown University Medical Center, Washington, D.C., United States of America, 3Departments of Biochemistry & Cellular and Molecular
Biology, Georgetown University Medical Center, Washington, D.C., United States of America
Abstract
Prenatal stress, psychologically and metabolically, increases the risk of obesity and diabetes in the progeny. However, the
mechanisms of the pathogenesis remain unknown. In adult mice, stress activates NPY and its Y2R in a glucocorticoid-
dependent manner in the abdominal fat. This increased adipogenesis and angiogenesis, leading to abdominal obesity and
metabolic syndrome which were inhibited by intra-fat Y2R inactivation. To determine whether stress elevates NPY system
and accelerates adipogenic potential of embryo, here we ‘‘stressed’’ murine embryonic stem cells (mESCs) in vitro with
epinephrine (EPI) during their adipogenic differentiation. EPI was added during the commitment stage together with
insulin, and followed by dexamethasone in the standard adipogenic differentiation medium. Undifferentiated embryonic
bodies (EBs) showed no detectable expression of NPY. EPI markedly up-regulated the expression NPY and the Y1R at the
commitment stage, followed by increased Y2R mRNA at the late of the commitment stage and the differentiation stage. EPI
significantly increased EB cells proliferation and expression of the preadipocyte marker Pref-1 at the commitment stage. EPI
also accelerated and amplified adipogenic differentiation detected by increasing the adipocyte markers FABP4 and PPARc
mRNAs and Oil-red O-staining at the end of the differentiation stage. EPI-induced adipogenesis was completely prevented
by antagonists of the NPY receptors (Y1R+Y2R+Y5R), indicating that it was mediated by the NPY system in mESC’s. Taken
together, these data suggest that stress may play an important role in programing ESCs for accelerated adipogenesis by
altering the stress induced hormonal regulation of the NPY system.
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Introduction
Obesity is a major problem in the Western world, and an
increasing challenge in the developing countries. In particular,
abdominal obesity is linked to chronic diseases such as type 2
diabetes, hypertension and cardiovascular disease, currently
recognized as major public health concerns [1,2]. Estimates
indicate that obesity is responsible for more than 300,000 deaths
each year in the United States alone, triggering the largest growth
in mortality over the past decade [3]. Owing to the increase in
obesity, life expectancy may start to decrease in developed
countries for the first time in the recent history [4].
Adipose tissue is one of the most dynamic tissues of the body,
expanding and shrinking in response to various hormonal,
neurogenic and nutritional stimuli due to both adipocyte
hypertrophy and hyperplasia [5,6,7]. The number of adipocytes
is set before adolescence, and stays relatively constant throughout
the adulthood [7], while adipose stem cells are mainly committed
in pregnancy [8]. In humans and rodents, prenatal stress increases
the risk of obesity and diabetes in the progeny [9,10]. However,
how stress affects adipogenic commitment in embryos, and
contributes to the adult obesity, remains unclear.
Adipogenesis is a developmental process by which mesenchymal
stem cells (MSCs) differentiate into mature adipocytes. Terminal
stages of adipogenic differentiation have been extensively studied
using immortalized preadipocyte lines [11]. However, very little is
known regarding the early steps of adipogenesis, in particular, the
molecular mechanisms and the cellular intermediates responsible
for the transitions from undifferentiated embryonic stem cells
(ESCs) to MSCs, and from MSCs to preadipocytes [12]. ESCs,
which are derived from the inner cell mass of the blastocyst
embryos, have the potential to differentiate into all cell types in vitro
and in vivo, thus representing an ideal study system for regenerative
medicine. ESCs can be maintained in an undifferentiated state in
the presence of leukaemia inhibitory factor (LIF) [13]. By adding
appropriate differentiation agents, ESCs can be committed to a
variety of cell types, including adipocytes [14], cardiac cells [15],
skeletal-muscle cells [16], neurons [17] and blood cell lineages [18].
Adipocytes arise from mesenchymal stem cells [19], a common
precursor for myocytes, chondrocytes and osteocytes. Once
committed to the adipocyte lineage, adipocyte progenitors mature
into adipocytes during the terminal stages of differentiation [20].
Stress has been linked to the pathogenesis of obesity in adult
animals and humans [21,22]. In our previous mouse study, stress
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diet-induced obesity by up-regulating the release of NPY and the
expression of its Y2 receptor (Y2R) within the adipose tissue. The
NPY-Y2R system increased fat accretion by directly stimulating
differentiation of adipocytes and by indirectly increasing angio-
genesis, both via Y2R [22].
NPY is a major sympathetic neurotransmitter activated by stress
[23,24,25]. Additionally, NPY is also expressed by non-neuronal
cells, including platelets/megakaryocytes, immune cells and
adipocytes [22,26]. The peptide has both central and peripheral
effects that are important in cardiovascular, neuro-endocrine and
metabolic adaptations to environmental and nutritional stress
which has the potential to threaten the organism’s ability to
survive [27]. On the cellular level, NPY has been implicated in
promoting growth and/or differentiation of a variety of cells, in a
receptor-specific manner. Via its Y1R, NPY stimulates prolifer-
ation of neuroprogenitors [28] and osteoblasts [29], whereas via
the Y2R/Y5R it promotes angiogenesis and preadipocyte 3T3-L1
differentiation [22]. The latter, the Y2R mediated actions appear
to require the presence of dipeptidyl peptidase IV (DPPIV).
DPPIV cleaves NPY1–36 to a shorter form, NPY3–36, which is
inactive for the Y1R and selectively activates the Y2R and the
Y5R [22]. NPY has also been shown to stimulate proliferation of
human embryonic stem cells mediated by the Y1R and Y5R [30].
Stress induces a cascade of adaptive neuroendocrine responses,
which classically includes secretion of cortisol and epinephrine
(EPI) into the circulation from the adrenal gland [31]. Following
sympathetic nerve activation, NPY and norepinephrine (NE) are
co-released, activating various physiological processes [32], both
synergistically and independently. For example, EPI [33] and
glucocorticoids [22] increase NPY expression and signaling [34] in
both neuronal and non-neuronal cells. To examine the effects of
stress and its mediators in embryonic adipogenesis, we treated
mESCs with stress hormone EPI. Here we demonstrate that EPI
up-regulates NPY expression, which accelerates and amplifies
adipogenic differentiation of mESCs.
Results
EPI increased the expression of NPY and its receptors in
mESCs
We used the five-stage method to direct the differentiation of
mESCs into adipocytes (Figure 1A). First, we expanded the
undifferentiated mESCs in the presence of LIF (stage 1). When
LIF is withdrawn, mESCs spontaneously differentiated into three-
dimensional cellular aggregates or embryonic bodies (EBs) in
suspension (stage 2). Two days later, the EBs were treated with all-
trans retinoic acid (RA) for 3 days and entered the permissive stage
(stage3). Between day 7 and day 17, a period known as the
commitment stage (stage 4), cells were exposed to insulin which
induced their commitment to the adipose cell lineage. The final
stage (stage 5), between day 17 to day27, is known as the terminal
differentiation stage, when the cells are exposed to the classic
adipogenic factors: insulin, dexamethasone (Dex) and methyliso-
butylxanthine (IBMX).
To investigate the role of the stress hormone EPI in the
regulation of NPY and its receptors in ESCs, EPI was added from
day 7 to day 17 during the commitment stage, and cells were
harvested for detection of mRNA expression of NPY, Y1R, Y2R
and DPPIV at the different time points. In undifferentiated EBs,
NPY was undetectable but became up-regulated during adipo-
genic differentiation with insulin at the commitment stage
(Figure 1B). EPI markedly enhanced the expression of NPY at
that stage (Figure 1B). The up-regulation of the expression of NPY
was mirrored by the up-regulation of the Y1R mRNA (Figure 1C)
at the commitment stage and this was followed by up-regulation of
the Y2R at the late of commitment stage and the differentiation
stage (Figure 1D). DPPIV mRNA was also upregulated at the
differentiation stage (Figure 1E). EPI markedly increased the NPY
and Y1R expression at the commitment stage (Figure 1C), which
peaked on day 4 of insulin-induced adipogenic commitment
(Figure 1C). No difference in DPPIV expression was observed
during the commitment stage (Figure 1E).
EPI augmented and accelerated differentiation of mESCs
into adipocytes
At the end of differentiation, we measured mature adipocytes in
EB outgrowths by oil red-O staining, a specific stain for
triglycerides. mESCs treated with EPI during the commitment
stage had more adipocytes compared to standard medium,
indicating that EPI-induced stress stimulated adipogenesis
(Figure 2A). Treatment with insulin during commitment stage
from day 7 to day 17 promoted a high rate of adipogenesis
resulting in the formation of adipocyte colonies in 60% of EB
outgrowths (Figure 2B). Co-treatment with EPI during this stage
significantly increased adipogenesis, resulting in more than 90% of
the EB outgrowths forming adipocytes (Figure 2B). This suggested
that EPI induced adipocytes commitment in mESCs [35]. Co-
treatment with EPI during this stage also increased the percentage
of adipocytes per EB outgrowth, suggesting that EPI also promote
the terminal differentiation (Figure 2C) [12]. EPI markedly
upregulated the expression of the adipocyte markers FABP4 and
PPARc at the end of differentiation (Figure 2D–E) in parallel to
increase of the Y2R and DPPIV mRNAs at this stage, compared
to standard control (Figure 1D–E).
EPI-induced adipogenesis is mediated by the NPY system
EPI significantly increased EB cells proliferation at the
commitment stage (Figure 3). Consistent with the EPI-induced
upregulation of percentage of EB outgrowths with adipocyte
colonies (Figure 2B), EPI markedly increased the expression of the
preadipocyte marker Pref-1 at the commitment stage, (Figure 4),
indicating that EPI induces more cells committed to preadipocytes
stage.
To explore whether the effects of EPI-induced mESCs
adipogenesis were mediated by the NPY system, antagonists of
the NPY receptors (Y1R+Y2R+Y5R) were added during the
commitment stage together with EPI. Antagonists of the NPY
receptors completely blocked the effects of EPI on up-regulation of
the expression of the preadipocyte marker Pref-1 (Figure 4) during
the commitment stage. The EPI-induced increase in EB cells
proliferation was also blocked by antagonists of the NPY receptors
(Figure 3). Finally, antagonists of the NPY receptors
(Y1R+Y2R+Y5R) completely prevented the effects of EPI-induced
stress on adipogenic differentiation, measured by oil red-O
staining and expression of adipocyte markers at the end of
differentiation (Figure 5). Antagonists of the NPY receptors also
blocked the effects of EPI on increase of percentage of EB
outgrowths with adipocytes and percentage of adipocytes per
outgrowths (Figure 5B–C).
Discussion
Stress has been linked to obesity via multiple mechanisms:
centrally, through its hypothalamic actions on food intake, and
peripherally, via direct actions on adipose tissue of sympathetic
neurotransmitters, NPY [22] and catecholamines [36], parasym-
pathetic activity [37] and glucocorticoids [38]. Activation of EPI is
NPY Mediates Stress-Induced Adipogenesis in mESCs
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to induce lipolysis in the white fat [36], and thermogenesis in the
brown fat [39]. EPI regulates lipolysis in human adipocytes
through stimulatory b1- and b2-adrenoreceptors or inhibitory a2-
adrenoreceptors [36]. However, the roles of EPI on ESCs
differentiation to adipocytes have not been investigated. Here we
report that EPI markedly enhanced and accelerated adipogenesis
by activating the NPY system in mESCs. We found that EPI
stimulated EB cells proliferation (Figure 3) and their commitment
to preadipocytes (Figure 4). EPI increased the expression of the
preadipocyte marker Pref-1(Figure 4). Pref-1 is specifically
expressed in preadipocytes but not in adipocytes and it is used
as a preadipocyte marker for MSCs commitment to the adiogenic
lineage [8,40,41]. EPI-induced up-regulation of Pref-1 indicates
that more preadipocytes were committed at this stage, which is
consistent with that EPI-induced upregulation of the percentage of
EB outgrowths with adipocyte colonies (Figure 2B). Others [42]
reported similar effects for thyroid-stimulating hormone (TSH),
the main regulator of thyroid growth and function, which has been
implicated in the induction of lipolysis in adult animals and was
shown to stimulate adipogenesis in mESCs.
Catecholmines, such as EPI in the adrenal medulla and NE in
the sympathetic nerves, are important mediators of physiological
processes during stress. NPY is co-released with both of them
[31,32], providing a rationale for a functional interaction between
catecholamines and NPY. The co-transmission between NPY and
EPI has already been demonstrated in the cardiovascular system,
where both EPI-induced vasoconstriction and NE-mediated
growth of cardiomyocytes are potentiated by co-administration
of NPY [43]. In immune cells, EPI-induced inhibition of IL-6
release from macrophages in ex vivo superfused spleen slices is
significantly modulated by NPY via its Y1R [44]. Furthermore,
EPI-induced leukocytosis is mediated by Y1R and Y5R during
leukocyte mobilization [44]. In the present study, EPI markedly
up-regulated NPY and stimulated adipogenesis mediated by NPY
receptors in mESCs (Figure 5). Antagonists of the NPY receptors
(Y1R+Y2R+Y5R) completely blocked the effects of EPI on stem
cell proliferation and differentiation (Figure 3, 5). However, adding
Y1R antagonist, Y2R antagonist or Y5R antagonist separately
during the commitment stage together with epinephrine from day
7 to 17; none of them alone efficiently blocked the EPI-induced
adipogenic effects (data not shown).
Understanding the physiological role of NPY is challenging,
since up to now five NPY receptors have been cloned, Y1R,
Y2R,Y4R, Y5R and Y6R [45], representing G-coupled recep-
tors. Of those, only theY1R requires the whole NPY1–36 molecule
for its activation. The Y1R has been show to stimulate
proliferation of many cells [46], including vascular smooth muscle
[47] and human embryonic stem cells [30]. In contrast, the shorter
form NPY3–36, a product of DPPIV cleavage, while inactive for
Figure 1. Epinephrine up-regulated the NPY system during mESCs adipogenesis. (A) Schematic representation of the strategy for
differentiation of mESCs into adipocytes. (B–G) Gene expression analysis of NPY system during mESCs adipogenesis. EBs were treated with insulin
(standard, STD) or insulin plus 1 mM EPI (EPI) from day 7 to day 17 during commitment stage, mRNA levels of NPY (B), Y1R (C), Y2R (D) and DPPIV (E)
were measured by real time PCR. b-actin expression was used as an internal control. Values are from three separate experiments each performed in
triplicate. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0036609.g001
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proliferation of endothelial cells as well as adipogenesis of
preadipocytes [22]. TheY2R and increased levels of NPY in the
adipose tissue mediated the accelerated fat accretion induced by
chronic stress in adult male mice fed high fat diets [22], leading to
abdominal obesity and metabolic-like syndrome. All of these
effects of stress were completely prevented by intra-fat Y2R
inactivation [22]. While other groups have also reported that the
Y1R plays a role in adipogenesis by increasing preadipocyte
proliferation [48], the role of the Y5R in adipogenesis remains to
be examined further.
In the current study, we hypothesized that NPY and its Y1R
and Y2R are sequentially activated and play an important role in
the regulation of embryonic stem cell differentiation to adipocytes,
particularly under conditions of stress. We propose that the Y1R
and Y2R have complementary effects on adipogenesis, where
activation of the Y1R leads to proliferation while activation of
theY2R promotes adipogenic differentiation. This notion was
based on recent findings in 3T3-L1 cells, where the Y1R is highly
expressed in preadipocytes and markedly decreased in matured
adipocytes. On the other hand, the expression of the Y2R is low in
preadipocytes and significantly increased in mature adipocytes
Figure 2. Epinephrine augmented and accelerated the differentiation of mESCs into adipocytes at the end of differentiation. (A)
Images of adipocytes developed from EBs treated without insulin at the end of differentiation (day 27) (CTL), with insulin (STD) or insulin plus
epinephrine (EPI) added from day 7 to day 17 during commitment stage. Scale bars=150 mm. (B) Percentage of EB outgrowths with adipocyte
colonies and (C) percentage of adipocytes per EB outgrowth were measured and quantified at day 27. (D–E) Gene expression of adipocyte markers
was measured by real time PCR at the end of the differentiation (day 27). RNA was isolated from differentiated mESCs and analyzed for expression of
adipocyte marker genes FABP4 and PPARc. b-actin expression was used as an internal control. Values are from three separate experiments each
performed in triplicate. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0036609.g002
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Y1R and theY2R was found in the current study in the ESCs,
where EPI markedly increased the Y1R expression at the
commitment stage while up-regulating the expression of the
Y2R and DPPIV at the differentiation stage. The high expression
of the Y2R and DPPIV in the later adipogenic stage is consistent
with our previous data in vivo showing that stress-induced up-
regulation and activation of the Y2R and DPPIV mRNAs in the
visceral fat is associated with rapid development of abdominal
obesity and metabolic syndrome in adult mice [22].
How the NPY expression is regulated in cells during adipogenic
differentiation is not well understood. Epigenetic regulators, such
as histone modification and DNA methylation, have been
implicated in influencing ESCs self-renewal and differentiation
[49]. The NPY gene is rich in CpG islands and is highly hyper-
methylated in most of available human embryonic stem cell lines
[50]. NPY is suggested to be one of only 25 genes whose silencing
is required for totipotency of these cells. In contrast, NPY gene is
hypo-methylated in somatic tissues and many differentiated cells
[50]. In our pilot studies, we assessed DNA methylation at 3 sites
of the NPY promoter, including calmodulin-responsive element
(CaM-RE), nerve growth factor responsive element (NGF-RE),
and cAMP-RE, using methylation specific real time PCR (data not
shown). In undifferentiated murine embryonic bodies, these
regions showed high level of DNA methylation and NPY mRNA
was undetectable. However, EPI induced up-regulation of NPY
expression associated with significant decrease in DNA methyla-
tion at the NGF-RE and CaM-RE sites (data not shown). Previous
studies have already demonstrated that NGF, glucocorticoids and
EPI are strong promoters of NPY expression in many cells
[22,33,34,51]. Stimulation of the calmodulin pathway was also
reported with increased adipogenesis of the ESCs [52]. Therefore,
our observations shed new light on mechanisms by which stress
may induce epigenetic changes in the NPY system, and thus
stimulate future adipogenesis during embryogenesis.
Figure 3. The NPY receptors antagonists blocked epinephrine-
induced proliferation of EB cells. Four EBs per well were plated on
gelatin-coated 12-well plates at day 7 and treated with insulin (STD),
insulin plus epinephrine (EPI), insulin plus EPI and NPY receptors
(Y1R+Y2R+Y5R) antagonists (CCT). The number of cells was measured at
day 7 and day 17. Values are from three separate experiments each
done in ten wells. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0036609.g003
Figure 4. The NPY receptors antagonists prevented the effects
of epinephrine on up-regulation of the preadipocyte marker
Pref-1 at commitment stage. EBs were treated with insulin (STD),
insulin plus epinephrine (EPI) or insulin plus EPI and NPY receptors
antagonists (CCT) from day 7 to day 17. RNA was isolated after 10days
of treatment and the expression of preadipocyte marker Pref-1 was
measured by RT-PCR. b-actin expression was used as an internal control.
Values are from three separate experiments each performed in
triplicate*p,0.05, **p,0.01.
doi:10.1371/journal.pone.0036609.g004
Figure 5. Epinephrine-induced adipogenesis is mediated by
the NPY system. (A) EBs were treated with insulin (STD), insulin plus
epinephrine (EPI) or insulin plus EPI and NPY receptors antagonists
(CCT) from day 7 to day 17.Final differentiated adipocytes were
detected by oil red O-staining. Scale bars=150 mm. (B) Percentage of EB
outgrowths with adipocyte colonies and (C) percentage of adipocytes
per EB outgrowth were measured and quantified at day 27. (D–E) mRNA
levels of adipocyte markers were measured by RT-PCR at the end of the
differentiation. RNA was isolated from differentiated mESCs at day 27,
and analyzed for expression of adipocyte marker genes FABP4 (D) and
PPARc (E). b-actin expression was used as an internal control. Values are
from three separate experiments each perfoemed in triplicate *p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0036609.g005
NPY Mediates Stress-Induced Adipogenesis in mESCs
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demonstrated prenatal stress has long term, programming effects
on obesity and metabolic syndrome [53,54]. Here we show that
the stress hormone EPI stimulates ESC adipogenesis mediated by
the NPY system. Our data suggested that NPY system mediates
stress induced adipogenic commitment in embryo, and thus play
an important role in prenatal stress programmed abdominal
obesity and metabolic syndrome in offspring.
Materials and Methods
Materials
NPY was obtained from Bachem (San Carlos, CA), Y1R
antagonist, BIBP 3226 from Sigma-Aldrich (St. Louis, MO); Y2R
antagonist, BIIE 0246 formate and Y5R antagonist, CGP71683,
from Tocris (Ellisville, MO).
Cell culture
The CCE mESC line was a generous gift from Dr. Ian
Gallicano (Georgetown University, Washington DC) [55]. Murine
ESC were grown in gelatin-coated flasks and maintained in
Dulbecco’s Modified Eagle’s Medium (DMEM) with 4.5 g/l d-
glucose, supplemented with 15% (vol/vol) fetal bovine serum
(FBS, Stemcell Technologies), 100 U/ml penicillin, 100 mg/ml
streptomycin, 0.1 mM non-essential amino acids, 10 ng/ml
murine recombinant leukemia inhibitory factor (LIF; Stemcell
Technologies), 0.1 mM monothioglycerol, and 2 mM L-glutamine
and 1 mM sodium pyruvate (Invitrogen). Adipogenesis was
induced as described previously in detail [56] with minor
modifications. On day 0, cells were trypsinized and resuspended
at 10
5 cells/ml in the same media as above without added LIF.
Drops (10 ml) were plated on the bottom of a 10 cm petri dish
(Fisher), and plates were cultured upside-down. On day 2, plates
were flipped and the embryonic bodies (EBs) were flooded with
media containing 10
27 M all-trans retinoic acid (Sigma-Aldrich).
This media was changed daily to prevent EBs from adhering to the
dish. On day 5, media without retinoic acid was added, and on
day 7, EBs were collected and plated on gelatin-coated six-well
plates. At this point, 5 mg/ml insulin (Sigma-Aldrich) was added to
the media for 10 days. On day 17, media was replaced media
containing with dexamethasone (Dex) (400 ng/ml; Sigma-Aldrich)
and methylisobutylxanthine (IBMX) (500 nM; Sigma). On day 19,
DEX and IBMX were removed from the media, and the cells were
cultured for 10 additional days in the insulin-containing media to
achieve fully differentiate adipocytes. Cells were harvested at
indicated times (Figure 1). EPI (1 mM) was were added daily,
between day 7 to day 17 with or without the antagonists of the
NPY receptor (Y1R+Y2R+Y5R) at the concentration of 0.1 mM
each.
Reverse transcription and Real-time PCR
RNA was isolated using Roche RNA isolation kit and cDNA
synthesized by iScriptcDNA synthesis kit (BioRad). Real-time
PCR was performed using the ICycleriQ Detection System
(BioRad) and theTaqMan PCR Reagent Kit with pre-designed
primers and fluorescently labeled probes with the duplicates. The
primers were from the Applied Biosystems: b- actin, 16403392;
NPY, 16403380; Y1R,16403381; Y2R,14381272; DDPIV,
16403393; FABP4, Mm00445880; PPARc, Mm01184322; Pref-
1, Mm00494477. The mRNA expression levels were calculated
using the comparative CT method with b-actin as the endogenous
reference gene, in accordance withthe Applied Biosystems’ ABI
PRISM, as described previously [22].
Oil red O staining
At the end of adipogenic differentiation, mESCs cells were fixed
in 4% Paraformaldehyde (PFA, USB Corporation) for 8 min,
stained with Oil Red O for 30 min at room temperature and
imaged (Nikon, Melville, NY).
Statistical analysis
The Kruskal-Wallis test for non-parametric measures was
applied to compare between treatment groups; p,0.05 was
considered statistically significant. Man Whitney U non-paramet-
ric test was used to analyze the effects of a single treatment
compared to control.
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